We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

209 hedge funds and large institutions have $3.43B invested in Beam Therapeutics in 2021 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 66 increasing their positions, 43 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

364% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 14

100% more funds holding in top 10

Funds holding in top 10: 5 → 10 (+5)

53% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 43

49% more call options, than puts

Call options by funds: $79.5M | Put options by funds: $53.2M

32% more funds holding

Funds holding: 158 → 209 (+51)

14% more capital invested

Capital invested by funds: $3.01B → $3.43B (+$422M)

5.22% more ownership

Funds ownership: 63.69% → 68.91% (+5.2%)

Holders
209
Holders Change
+51
Holders Change %
+32.28%
% of All Funds
3.67%
Holding in Top 10
10
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+100%
% of All Funds
0.18%
New
65
Increased
66
Reduced
43
Closed
14
Calls
$79.5M
Puts
$53.2M
Net Calls
+$26.3M
Net Calls Change
+$44.6M

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$347M
2
MM
MWG Management
British Virgin Islands
+$225M
3
FCM
Farallon Capital Management
California
+$56.4M
4
PA
Perceptive Advisors
New York
+$51.1M
5
Victory Capital Management
Victory Capital Management
Texas
+$49.1M

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$119M
2
HA
HHLR Advisors
Cayman Islands
-$85M
3
CAM
Cormorant Asset Management
Massachusetts
-$71.6M
4
Fidelity International
Fidelity International
Bermuda
-$66.4M
5
Alkeon Capital Management
Alkeon Capital Management
New York
-$40.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
51
Citigroup
New York
$3.68M +$3.23M +33,935 +282%
New York State Common Retirement Fund
52
New York State Common Retirement Fund
New York
$3.65M – – –
Wells Fargo
53
Wells Fargo
California
$3.65M +$707K +7,432 +19%
RhumbLine Advisers
54
RhumbLine Advisers
Massachusetts
$3.5M -$241K -2,536 -5%
Swiss National Bank
55
Swiss National Bank
Switzerland
$3.18M +$133K +1,400 +4%
ETCM
56
Evolutionary Tree Capital Management
Virginia
$3.12M +$1M +10,553 +37%
UBS Group
57
UBS Group
Switzerland
$3.08M +$1.6M +16,773 +77%
Renaissance Technologies
58
Renaissance Technologies
New York
$3.05M +$3.62M +38,100 New
PCM
59
Pathway Capital Management
California
$2.99M +$3.56M +37,399 New
Squarepoint
60
Squarepoint
New York
$2.95M +$3.5M +36,817 New
Two Sigma Investments
61
Two Sigma Investments
New York
$2.73M +$3.24M +34,076 New
Rafferty Asset Management
62
Rafferty Asset Management
New York
$2.71M +$2.19M +23,029 +213%
EC
63
Euclidean Capital
New York
$2.49M +$2.96M +31,131 New
BHCM
64
Brevan Howard Capital Management
Jersey
$2.4M +$2.85M +30,000 New
Jane Street
65
Jane Street
New York
$2.2M +$332K +3,486 +15%
Russell Investments Group
66
Russell Investments Group
United Kingdom
$2.19M +$2.05M +21,565 +371%
JF
67
Jump Financial
Illinois
$2.19M +$2.6M +27,338 New
Ensign Peak Advisors
68
Ensign Peak Advisors
Utah
$2.16M -$8.87M -93,273 -78%
Susquehanna International Group
69
Susquehanna International Group
Pennsylvania
$2.13M -$3.95M -41,547 -61%
Vontobel Holding
70
Vontobel Holding
Switzerland
$2.07M +$2.47M +25,914 New
MAM
71
Myriad Asset Management
Hong Kong
$2.02M +$2.4M +25,200 New
Legal & General Group
72
Legal & General Group
United Kingdom
$2.02M +$1.62M +16,994 +207%
LCM
73
Laurion Capital Management
New York
$2M – – –
CS
74
Credit Suisse
Switzerland
$1.91M -$3.32M -34,927 -59%
VF
75
Virtu Financial
New York
$1.78M +$2.12M +22,256 New
1 2
3
4 5

BEAM Hedge Fund Activity: Q1 2021 in Review

209 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q1 2021, worth a combined $3.43B — up 14% from $3.01B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new BEAM positions and 14 closed out — a net gain of 51 holders — while 66 added to existing stakes and 43 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $347M. The largest seller was Redmile Group, cutting an estimated $119M.

  • 209 institutional investors held Beam Therapeutics (BEAM) as of Q1 2021, up from 158 in Q4 2020.
  • Funds reported $3.43B of Beam Therapeutics stock for Q1 2021, up 14% quarter-over-quarter.
  • 65 funds opened new Beam Therapeutics positions in Q1 2021 and 14 closed out, a net change of +51 holders.
  • The largest Beam Therapeutics buyer in Q1 2021 was ARK Investment Management, an estimated $347M added.
  • The largest Beam Therapeutics seller in Q1 2021 was Redmile Group, an estimated $119M sold.

Based on aggregated 13F filings for Q1 2021.